4Eyetech Study Group.Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration:phase Ⅱ study results.Ophthalmology,2003,110:979-986.
5Gragoudas ES,Adamis AP,Cunnigham ET,et al.VEGF inhibition study in ocular neovascularization clinical trial group.Pegaptanib for neovascular age-related macular degeneration.N Engl J Med,2004,351:2805-2816.
7The PKC-DRS Study Group.The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy:initialresultsof the protein kinase C beta inhibitor diabetic retinopathy study(PKC-DRS)multicenter randomized clinical trial.Diabetes,2005,54:2188-2197.
8Poulaki V,Jaussen AM,Mitsiades N,et al.Insulin like growth factor-Ⅰ plays a pathogenetic role in diabetic retinopathy.Am J Pathol,2004,165:457-469.
9Sall J,Klisovic D,O'Dorisio M,et al.Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells.Exp Eye Res,2004,79:465-476.
10Leibovitch I,Loewenstein A,Alster Y,et al.Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.Ophthalmic Surg Lasers Imaging,2004,35:16-22.
